| Medical and Health Sciences | Lifetime | 406 | US 218 | 99.98 |
| Economics and Finance | Lifetime | 90 | US 60 | 99.91 |
| Econometrics and Quantitative Economics | Lifetime | 43 | US 28 | 99.93 |
| Pharmacology | Lifetime | 17 | US 12 | 99.81 |
| Geriatrics and Gerontology | Lifetime | 16 | US 13 | 99.60 |
| Family Practice | Lifetime | 8 | US 4 | 99.26 |
| General Health Professions | Lifetime | 707 | US 369 | 99.20 |
| Pediatrics, Perinatology and Child Health | Lifetime | 313 | US 148 | 99.09 |
| Public, Environmental and Occupational Health | Lifetime | 892 | US 463 | 98.72 |
| Cardiology and Cardiovascular Medicine | Lifetime | 780 | US 410 | 98.39 |
| Clinical Pharmacology | Lifetime | 852 | US 362 | 96.00 |
| Statistics and Probability | Lifetime | 830 | US 456 | 91.93 |
| Nephrology | Lifetime | 767 | US 353 | 88.54 |
| Econometrics and Quantitative Economics | 2021-2025 | 784 | US 215 | 95.06 |
| Pharmaceutical Economics and Policy | Lifetime | 1 | US 1 | 99.87 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 2 | US 2 | 99.89 |
| Pharmaceutical studies and practices | Lifetime | 3 | US 3 | 99.88 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 22 | US 9 | 99.89 |
| Medication Adherence and Compliance | Lifetime | 3 | US 3 | 99.81 |
| Pharmaceutical industry and healthcare | Lifetime | 1 | US 1 | 99.82 |
| Biomedical Ethics and Regulation | Lifetime | 8 | US 6 | 99.00 |
| Health and Medical Research Impacts | Lifetime | 21 | US 11 | 98.90 |
| Biotechnology and Related Fields | Lifetime | 13 | US 7 | 98.30 |
| Healthcare cost, quality, practices | Lifetime | 57 | US 33 | 98.74 |
| Healthcare Policy and Management | Lifetime | 169 | US 125 | 98.86 |
| Innovations in Medical Education | Lifetime | 271 | US 108 | 98.11 |
| Blood Pressure and Hypertension Studies | Lifetime | 432 | US 189 | 98.73 |
| Lipoproteins and Cardiovascular Health | Lifetime | 364 | US 181 | 98.43 |
| Inflammatory mediators and NSAID effects | Lifetime | 390 | US 192 | 97.63 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 78 | US 27 | 97.05 |
| Advanced Causal Inference Techniques | Lifetime | 133 | US 93 | 95.71 |
| Biosimilars and Bioanalytical Methods | Lifetime | 301 | US 106 | 95.09 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 903 | US 310 | 96.37 |
| Antibiotic Use and Resistance | Lifetime | 720 | US 242 | 95.93 |
| Statistical Methods in Clinical Trials | Lifetime | 607 | US 316 | 93.92 |
| Patient Safety and Medication Errors | Lifetime | 708 | US 346 | 92.75 |
| Intellectual Property and Patents | Lifetime | 481 | US 198 | 88.25 |
| Science, Research, and Medicine | Lifetime | 297 | US 151 | 83.49 |
| Pharmacy and Medical Practices | Lifetime | 948 | US 260 | 77.69 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 691 | US 229 | 94.52 |
| Pharmaceutical Economics and Policy | 2021-2025 | 280 | US 106 | 86.62 |
| Biomedical Ethics and Regulation | 2021-2025 | 259 | US 104 | 78.41 |
| Pharmaceutical industry and healthcare | 2021-2025 | 102 | US 50 | 76.53 |
